Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Warfarin therapy in a patient homozygous for the CYP2C9 3 allele.

The Israel Medical Association journal : IMAJ - 1 Feb 2002

Ablin Jacob, Cabili Shaltiel, Lagziel Ayala, Peretz Hava

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Failure

Share to Steroid 16-alpha-Hydroxylase

Share to Steroid Hydroxylases

Share to Warfarin

Source

Identifiers

PMID: 11875991

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Warfarin therapy in a patient homozygous for the CYP2C9 3 allele.PMID 11875991Read ↗

Severely diminished response to vitamin K-treatment for self-inflicted warfarin intoxication in a patient genotyped as CYP2C9*3*3.Semantic proximity Read ↗

Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.Semantic proximity Read ↗

A novel CYP2C9 variant that caused erroneous genotyping in a patient on warfarin therapy.Semantic proximity Read ↗

Warfarin dose requirement for patients with both VKORC1 3673A/A and CYP2C9*3/*3 genotypes.Semantic proximity Read ↗

Standard warfarin dose in a patient with the CYP2C9*3/*3 genotype leads to hematuria.Semantic proximity Read ↗

A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.Semantic proximity Read ↗

Low dose requirement for warfarin treatment in a patient with CYP2C9*3/*13 genotype.Semantic proximity Read ↗

Major bleeding during combined treatment with indomethacin and low doses of acenocoumarol in a homozygous patient for 2C9*3 variant of cytochrome p-450 CYP2C9.Semantic proximity Read ↗

A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.Semantic proximity Read ↗

The CYP3A4*3 allele: is it really rare?Semantic proximity Read ↗

Pharmacogenetics of warfarin elimination and its clinical implications.Semantic proximity Read ↗

CYP2C9*3 allelic variant and bleeding complications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.